Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations

Advances in molecular tumour diagnostics and the number of targeted therapies increase rapidly. Molecular tumour boards (MTBs) are designated to interpret these data and provide clinical recommendations. Not all patients with cancer have access to advice of an MTB. We aimed to determine the current...

Descripción completa

Detalles Bibliográficos
Autores principales: Willemsen, Annelieke E. C. A. B., Krausz, Sarah, Ligtenberg, Marjolijn J. L., Grünberg, Katrien, Groen, Harry J. M., Voest, Emile E., Cuppen, Edwin P. J. G., van Laarhoven, Hanneke W. M., van Herpen, Carla M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738039/
https://www.ncbi.nlm.nih.gov/pubmed/31130724
http://dx.doi.org/10.1038/s41416-019-0489-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738039/
https://www.ncbi.nlm.nih.gov/pubmed/31130724
http://dx.doi.org/10.1038/s41416-019-0489-3

Ejemplares similares